Thursday, January 20, 2022

BioTheryX Names Chief Business Officer

San Diego-based biopharmaceuticals company BioTheryX said today that it has named Sahm Nasseri as Chief Business Officer. Nasseri was previously CEO of PYC Therapeutics, an RNA therapeutics company based in the United States and Australia. In addition, Nasseri served at Merck & Co., serving as interim Vice President and Global Product Leader for Merck's HPV Vaccines, and also was at McKinsey & Company.